Pharmaceutical Technology, October 2012 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2012
Volume 36
Issue 10

Combination Drugs - Adding Up the Opportunities in Solid Dosage

External Link - article-806811.pdf

Articles in this issue
Pharmaceutical Technology, October 2012 Issue (PDF)
Integration of Less-Formal Risk Assessment Tools into Change Control
Integration of Less-Formal Risk Assessment Tools into Change Control
Technical Forum: Disposable Chromatography
Technical Forum: Disposable Chromatography
i8_t-791912-1408595509997.jpg
Uniformity of Dosage Units Using Large Sample Sizes
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
i1-791910-1408595518060.jpg
A World without R&D
Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
Supplier Qualification
Supplier Qualification
Advancing Protein Crystallization: Microgravity Effects and Predictive Models
Determining Potency of Preclinical Dose Formulations
Determining Potency of Preclinical Dose Formulations
Report from India
Report from India
i1-791898-1408595560153.jpg
Tools in Waiting: Time for Evolutionary Operation
Outsourcing Pharmaceutical Infrastructure Operations
Outsourcing Pharmaceutical Infrastructure Operations
Case Closed
Obtaining Stable Homogenous Mixtures with Micronized APIs
Obtaining Stable Homogenous Mixtures with Micronized APIs
Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Gerresheimer and Bormioli Pharma to Showcase Containment Solutions at Pharmapack

Susan Haigney
January 20th 2025
Article

The two companies will be exhibiting together after Gerresheimer’s December 2024 acquisition of Bormioli.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Almac Sciences Invests £500K in Spectroscopy Lab Instrumentation

Patrick Lavery
January 16th 2025
Article

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Lyndra, Thermo Fisher to Partner on R&D for Long-Acting Oral Therapies

Patrick Lavery
January 15th 2025
Article

The collaboration will leverage Thermo Fisher’s Accelerator Drug Development stable of solutions, which was launched in the fall of 2024.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Feliza Mirasol
January 15th 2025
Article

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.